| NCT ID | NCT05543200 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Société Internationale d'Urologie |
| Condition | Benign Prostatic Hyperplasia |
| Study Type | OBSERVATIONAL |
| Enrollment | 7,500 participants |
| Start Date | 2023-03-13 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 7,500 participants in total. It began in 2023-03-13 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Benign prostatic hyperplasia (BPH) is one of the most common performed surgical procedures in urology. Over the past few decades there have been an increasing development of newer surgical treatment options. Additionally, the outcome parameters for BPH treatments have been standardized. While data are available for the initial pivotal studies, post-market release data are lacking. Under the umbrella of uCARE, we have started a prospective, ongoing international registry for recording demographics and outcomes for patients undergoing surgical treatments for BPH.
Eligibility Criteria
Inclusion Criteria: * Primary diagnosis of BPH with LUTS with prescribed medical treatment or surgical intervention Exclusion Criteria: * Non-symptomatic BPH * No treatment prescribed for BPH
Contact & Investigator
Mihir Desai, MD
PRINCIPAL INVESTIGATOR
University of Southern California
Frequently Asked Questions
Who can join the NCT05543200 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Benign Prostatic Hyperplasia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05543200 currently recruiting?
Yes, NCT05543200 is actively recruiting participants. Contact the research team at mihir.desai@med.usc.edu for enrollment information.
Where is the NCT05543200 trial being conducted?
This trial is being conducted at Los Angeles, United States, Toronto, Canada, Montreal, Canada, Montreal, Canada and 11 additional locations.
Who is sponsoring the NCT05543200 clinical trial?
NCT05543200 is sponsored by Société Internationale d'Urologie. The principal investigator is Mihir Desai, MD at University of Southern California. The trial plans to enroll 7,500 participants.